D70.1 - Agranulocytosis secondary to cancer chemotherapy

  • Applicable to Agranulocytosis secondary to cancer chemotherapy
  • The 2025 edition of ICD10-CM D70.1 became effective on October 1, 2024.
  • This is the American ICD10-CM version of D70.1 - other international versions of ICD10 D70.1 may differ.
  • D70.1 is a Billable / Specific ICD10-CM code that can be used to indicate a diagnosis for reimbursement purposes.

Code Additional Code

  • code for adverse effect, if applicable, to identify drug (T45.1X5)

codeAlso

  • underlying neoplasm

The following codes above D70.1 contain annotation back-references that may be applicable to D70.1:

Chapter: D50-D89 Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

Section: D70-D77 Other disorders of blood and blood-forming organs

Category: D70 Neutropenia

agranulocytosis icd 10
 
chemotherapy icd 10
 
cancer icd 10
 
Billable/Specific Code

Browse other similar CM codes

D70.0
 
D70.1
 
D70.2
 
D70.3
 
D70.4
 
D70.8
 
D70.9
 

Please, give attribution to our website icd-10code.com